drugset

drugset / Trial / NCT00316459

Study Evaluating the Effects of Multiple Oral Doses of ERB-041 on Cardiac Repolarization in Healthy Subjects

NCT00316459 ↗

Phase 1 Completed 64 enrolled Wyeth is now a wholly owned subsidiary of Pfizer

RandomizedCrossoverDouble-blindTreatment

Summary

To assess the effect of ERB-041 after multiple oral doses on cardiac repolarization as assessed by the QTc interval.

Timeline

Start: 2006-05
Primary completion: —
Completion: —

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	PRINABEREL	Small molecule	—	Oral

Indications